Paydens Limited yesterday (April 7) told C+D that the pharmacy chain is set for “sustainable long-term growth” despite reporting mounting losses for the year ending March 31 2024.
Paydens in ‘strong position’ following disposals and £14m loss
Paydens has stressed that the multimillion-pound loss reported in its new financial documents does “not accurately depict [its] current financial strength”.

Sign in or register for free
Already registered?
Latest from Business
It assesses whether the next funding contract will support pharmacists, keep patients safe, and offer long-term sustainability.
The ‘teleconsultation’ dispensing machine has pre-loaded medication ready to dispense for those in urgent need of medication when a community pharmacy is closed.
Paydens has stressed that the multimillion-pound loss reported in its new financial documents does “not accurately depict [its] current financial strength”.
More from News
A vet has been suspended for issuing a “false prescription” of tramadol for a dog she “randomly” picked that was actually intended for the treatment of her father.
Following the announcement of the long-awaited pharmacy funding deal, C+D sets out a timeline of when changes are due to be implemented over the course of the next year…